- Home
- ACXP vs PIII Comparison
ACXP vs PIII Comparison
Compare ACXP & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- PIII
- Stock Information
- Founded
- ACXP 2017
- PIII 2015
- Country
- ACXP United States
- PIII United States
- Employees
- ACXP N/A
- PIII N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- ACXP Health Care
- PIII Health Care
- Exchange
- ACXP Nasdaq
- PIII Nasdaq
- Market Cap
- ACXP 8.4M
- PIII 21.4M
- IPO Year
- ACXP 2021
- PIII N/A
- Fundamental
- Price
- ACXP $0.47
- PIII $6.23
- Analyst Decision
- ACXP Strong Buy
- PIII Buy
- Analyst Count
- ACXP 2
- PIII 2
- Target Price
- ACXP $10.00
- PIII $16.25
- AVG Volume (30 Days)
- ACXP 18.7M
- PIII 3.7K
- Earning Date
- ACXP 08-08-2025
- PIII 08-06-2025
- Dividend Yield
- ACXP N/A
- PIII N/A
- EPS Growth
- ACXP N/A
- PIII N/A
- EPS
- ACXP N/A
- PIII N/A
- Revenue
- ACXP N/A
- PIII $1,485,192,000.00
- Revenue This Year
- ACXP N/A
- PIII N/A
- Revenue Next Year
- ACXP N/A
- PIII $6.01
- P/E Ratio
- ACXP N/A
- PIII N/A
- Revenue Growth
- ACXP N/A
- PIII 9.79
- 52 Week Low
- ACXP $0.30
- PIII $6.00
- 52 Week High
- ACXP $3.33
- PIII $32.54
- Technical
- Relative Strength Index (RSI)
- ACXP 52.38
- PIII 42.33
- Support Level
- ACXP $0.45
- PIII $6.00
- Resistance Level
- ACXP $0.59
- PIII $6.46
- Average True Range (ATR)
- ACXP 0.08
- PIII 0.21
- MACD
- ACXP -0.01
- PIII 0.07
- Stochastic Oscillator
- ACXP 27.06
- PIII 33.33
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.